Table: Oncolys Biopharma - 6-MTH parent results
Aug 6 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2021 Jun 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 193 mln 136 mln
(+41.8 pct) (-78.1 pct)
Operating loss 633 mln loss 660 mln
Recurring loss 649 mln loss 662 mln
Net loss 650 mln loss 664 mln
EPS loss 39.45 yen loss 46.43 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T